TITLE

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations

AUTHOR(S)
Passaperuma, K; Warner, E; Causer, P A; Hill, K A; Messner, S; Wong, J W; Jong, R A; Wright, F C; Yaffe, M J; Ramsay, E A; Balasingham, S; Verity, L; Eisen, A; Curpen, B; Shumak, R; Plewes, D B; Narod, S A
PUB. DATE
June 2012
SOURCE
British Journal of Cancer;6/26/2012, Vol. 107 Issue 1, p24
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background:The addition of breast magnetic resonance imaging (MRI) to screening mammography for women with BRCA mutations significantly increases sensitivity, but there is little data on clinical outcomes. We report screening performance, cancer stage, distant recurrence rate, and breast cancer-specific mortality in our screening study.Methods:From 1997 to 2009, 496 women aged 25 to 65 years with a known BRCA1/2 mutation, of whom 380 had no previous cancer history, were enrolled in a prospective screening trial that included annual MRI and mammography.Results:In 1847 screening rounds, 57 cancers were identified (53 screen-detected, 1 interval, and 3 incidental at prophylactic mastectomy), of which 37 (65%) were invasive. Sensitivity of MRI vs mammography was 86% vs 19% over the entire study period (P<0.0001), but was 74% vs 35% from 1997 to 2002 (P=0.02) and 94% vs 9% from 2003 to 2009 (P<0.0001), respectively. The relative sensitivities of MRI and mammography did not differ by mutation, age, or invasive vs non-invasive disease. Of the incident cancers, 97% were Stage 0 or 1. Of 28 previously unaffected women diagnosed with invasive cancer, 1 BRCA1 mutation carrier died following relapse of a 3 cm, node-positive breast cancer diagnosed on her first screen at age 48 (annual breast cancer mortality rate=0.5%). Three patients died of other causes. None of the 24 survivors has had a distant recurrence at a median follow-up of 8.4 years since diagnosis.Conclusion:Magnetic resonance imaging surveillance of women with BRCA1/2 mutations will detect the majority of breast cancers at a very early stage. The absence of distant recurrences of incident cancers to date is encouraging. However, longer follow-up is needed to confirm the safety of breast surveillance.
ACCESSION #
77351139

 

Related Articles

  • Screen-film versus full-field digital mammography: comparison in breast cancer screening. Sigfússon, Baldur F.; Sigfússon, Baldur F // Acta Radiologica;Nov2005, Vol. 46 Issue 7, p663 

    Observes that full-field digital mammography (FFDM) has now been found to have a better cancer detection rate than screen-film mammography (SFM). Study in 2001 which showed that the lesser ability of FFDM to detect breast cancer was not statistically significant; Work presented by P. Skaane and...

  • Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Skaane, P.; Skjennald, A.; Young, K.; Egge, E.; Jebsen, I.; Sager, E. M.; Scheel, B.; SØvik, E.; Ertzaas, A. K.; Hofvind, S.; Abdelnoor, M.; Søvik, E // Acta Radiologica;Nov2005, Vol. 46 Issue 7, p679 

    Purpose: To compare cancer detection rates of screen‐film (SFM) and full‐field digital mammography (FFDM) with soft‐copy reading in a screening program including the initial positive scores for interval cancers and cancers in the subsequent screening round, and to analyze the...

  • False-positive mammograms cost billions in the USA.  // PharmacoEconomics & Outcomes News;Apr2015, Vol. 726 Issue 1, p17 

    The article offers information on a retrospective cohort study conducted in the U.S. on the total annual cost of false-positive mammograms and the overdiagnoses of breast cancer in women.

  • Estimation of Willingness to Pay For Mammographic Breast Cancer Screening Tests among Women in Tehran, Based On Contingent Valuation Method: 2010. Ghaderi, H.; Vatankhah, S.; Khoshkam, M.; Rohani, B. // Journal of Health Administration;2012, Vol. 15 Issue 47, p33 

    Introduction: Routine mammography screening and clinical breast examination are effective measures in reducing breast cancer mortality. Contingent valuation method (CVM) is a method for willingness to pay (WTP) estimation for cost benefit analysis in economics. In this study, the mean and the...

  • Impact of Risk Factors on Different Interval Cancer Subtypes in a Population-Based Breast Cancer Screening Programme. Blanch, Jordi; Sala, Maria; Ibáñez, Josefa; Domingo, Laia; Fernandez, Belén; Otegi, Arantza; Barata, Teresa; Zubizarreta, Raquel; Ferrer, Joana; Castells, Xavier; Rué, Montserrat; Salas, Dolores // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes and to compare the risk factors identified with those associated with...

  • Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers. Bosse, Kristin; Graeser, Monika; Goßmann, Axel; Hackenbroch, Matthias; Schmutzler, Rita; Rhiem, Kerstin // Archives of Gynecology & Obstetrics;Mar2014, Vol. 289 Issue 3, p663 

    Introduction: This study aimed at evaluating the efficacy of ultrasound for the early detection of breast cancers in BRCA1/2 mutation carriers. Methods: Between 01/1997 and 10/2008 221 BRCA1/2 mutation carriers participated in a breast cancer screening program which included semi-annual...

  • Breast screening `does not save lives'.  // Nature;10/25/2001, Vol. 413 Issue 6858, p764 

    Reports on lack of evidence that the mammography procedure helps detect breast cancer, based on a re-analysis of screening trials by Ole Olsen and Peter Gotzsche of the Nordic Cochrane Center in Copenhagen and the Cochrane Collaboration, an independent body that supports systematic reviews of...

  • Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program. Kalager, Mette; Adami, Hans-Olov; Bretthauer, Michael; Tamimi, Rulla M. // Annals of Internal Medicine;4/3/2012, Vol. 156 Issue 7, p491 

    Background: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that...

  • Mammograms have never been more convenient. Halstead, Jan // Nursing Standard;4/13/2011, Vol. 25 Issue 32, p29 

    Some people will always avoid their check-ups, says Jan Halstead.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics